2019-07-09: DiaSys India is proud to associated with PathKind
During launch of HbA1c net, a premium product of DiaSys Diagnostic Systems, Medgate Today interviewed Mr. Sanjeev Vashishtha, CEO of PathKind and Dr. Jan Gorka, CEO, DiaSys GmbH.
Mr. Vashishtha expressed his thoughts about partnership with DiaSys India. He is explicit about the service and after prompt sales support provided by team DiaSys.
Dr. Gorka explained the importance of HbA1c net in clinical outcome along with its unique features.